|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Long-lived asset impairment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss on asset disposal | |||||
| Other expense, net | |||||
| Net loss | |||||
| Net loss per common share, basic | |||||
| Net loss per common share, diluted | |||||
| Weighted-average number of shares used in computing net loss per common share, basic | |||||
| Weighted-average number of shares used in computing net loss per common share, diluted | |||||
| Comprehensive loss: | |||||
| Net loss attributable to common stockholders | |||||
| Other comprehensive items: | |||||
| Unrealized gain on marketable securities | |||||
| Total other comprehensive income | |||||
| Total comprehensive loss | |||||
Loading...